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Nitric oxide (NO) donors have recently been evaluated as
radiosensitizers of hypoxic cells in a model of metabolism-
induced hypoxia at high cell densities. Mitchell et al (1993, 1996)
demonstrated that 2-(N,N,-diethylamino)-diazenolate-2-oxide-Na+
(DEA/NO), SNAP and S-nitroso-L-glutathione (GSNO) at a
concentration of 1 mM, radiosensitized Chinese hamster V79 lung
fibroblasts to a similar extent as oxygen. Griffin et al (1996)
reported comparable activity for DEA/NO and (Z)-1-{N-[3-
aminopropyl]-N-[4-(3-aminopropylammonio)butyl-amino}-
diazen-1-ium-1,2-diolate (SPER/NO) with enhancement ratios of
2.8—3.0 in SCK mammary carcinoma cells exposed to 1—2 mM
radiosensitizer. Our laboratory investigated the radiosensitizing
activity of SNP in a panel of eight human pancreatic tumour cell
lines and found an overall enhancement ratio of 1.9 at 0.1 mM
(Verovski et al, 1996). At 0.3—1 mM, SNP caused almost complete
radiosensitization in hypoxic PSN1/ADR cells that was accom-
panied by restoration of radiation-induced DNA breakage up to
the level in aerated cells.
These data collectively confirm the high radiosensitizing effi-
ciency of NO donors at 1—2 mM and suggest a role of NO in the
fixation of DNA damage caused by radiation. Whether DNA is the
main target for NO, as was postulated by Howard-Flanders (1957),
or whether other mechanisms contribute to the enhanced DNA
damage remains unclear. As NO can interact with iron—sulphur
containing enzymes, this may result in the inhibition of cellular
respiration and sparing of the natural sensitizer oxygen (Mitchell
et al, 1996). This sensitizing effect mediated by residual oxygen
can be minimized under hypoxic conditions induced by nitrogen
gassing, a general approach to study radiosensitizers. Moreover,
the latter model of hypoxia allows the use of a broad range of cell
densities, which is a necessary step to establish whether the rate of
NO release is enhanced by the presence of cells. The NO donors
DEA/NO and SPER/NO are known to liberate NO by a purely
spontaneous mechanism (Maragos et al, 1991). Some NO donors,
such as SNAP and GSNO, have generally been assumed to release
NO in a spontaneous manner although the slow decomposition
rate of S-nitrosothiols appeared to underestimate their biological
effects (Kowaluk and Fung, 1990). In fact, the chemistry of S-
nitrosothiols containing NO as a nitrosonium cation (Stamler et al,
1992), supports the idea of reductive catalysis of NO release,
which may occur on the cellular membrane (Bates et al, 1991;
Kowaluk et al, 1990; Rochelle et al, 1994). In the report of
Mitchell et al (1996), the possibility of bioreductive generation of
NO from SNAP has not been explored, but NO output in a cell-
free system was apparently too low to account for radiosensitiza-
tion. The same conclusion was drawn for another nitrosonium-like
NO donor, SNP, whose bioreductive activation was found to be
responsible for radiosensitization (Verovski et al, 1996).
The objective of the present study was to examine whether
bioreductive release of NO from SNAP is implicated in hypoxic
cell radiosensitization. To verify this hypothesis we compared the
rate of NO release in the absence or presence of cells and related
NO measurements to radiosensitizing concentrations of SNAP in
hypoxia. Nitrogen gassing was chosen as a model of hypoxia
because it allows radiosensitizing experiments to be performed at
low cell densities and its use excludes possible sensitizing effects
due to oxygen sparing.
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Summary The radiosensitizing activity of S-nitroso-N-acetylpenicillamine (SNAP), a nitric oxide (NO) donor, was assessed in a model of
non-metabolic hypoxia achieved in an atmosphere of 95% nitrogen–5% carbon dioxide. A 10 min preincubation of hypoxic EMT-6 cells
(10 ´ 106 ml–1) with 0.1 and 1 mM SNAP before radiation resulted in an enhancement ratio of 1.6 and 1.7 respectively. The level of
spontaneous NO release, measured by a NO specific microsensor, correlated directly with the concentration of SNAP and was enhanced 50
times in the presence of cells. Dilution of the cell suspension from 10 to 0.1 ´ 106 ml–1 resulted in a 16-fold decline in NO release, but only a
twofold decrease in radiosensitization was observed. Preincubation of hypoxic cells with SNAP for 3 min up to 30 min caused an increasing
radiosensitizing effect. Extended preincubation of 100 min led to the loss of radiosensitization although the half-life of SNAP is known to be
4–5 h. Taken together, these observations suggest that SNAP generates NO predominantly by a bioreductive mechanism and that its
biological half-life is unlikely to exceed 30 min. The lack of correlation between free NO radical and radiosensitizing activity may reflect a role
of intracellular NO adducts which could contribute to radiosensitization as well.
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Chemicals
SNAP, (2)-1-[N-(3-ammoniopropyl)-N-(n-propyl)amino)diazen-
1-ium-1,2-diolat (PAPA/NO) and 2-(4-carboxyphenyl)-4,4,5,5-
tetramethylimidazoline-1-oxyl-3-oxide (carboxy-PTIO) were
purchased from Alexis Corporation (Laufelfingen, Switzerland).
Other chemicals were obtained from Sigma Chemical Co. (St.
Louis, MO, USA). The stocks of SNAP and PAPA/NO were
prepared in dimethylsulphoxide (DMSO) and 0.01 M sodium
hydroxide respectively.
Cell culture
Murine mammary adenocarcinoma EMT-6 cells were cultured in
RPMI-1640 medium (Gibco, Paisley, UK) supplemented with
10% bovine calf serum (HyClone Laboratories Logan, UT, USA)
at 37°C in 5% carbon dioxide/95% air.
Radiation
Cultures grown to early confluence were trypsinized, and the cells
were washed by centrifugation in medium and counted. All steps
in sample preparation and processing were performed at 0°C
unless otherwise stated. Hypoxia in a cell suspension was achieved
by repeated vacuum evacuation/injection (60/30 s) of 5% carbon
dioxide/95% nitrogen for 30 min. Hypoxic cells (0.1—10 ´ 106 ml—1
in 150 ml) placed in glass tubes were preincubated for 10 min
at 37°C with or without radiosensitizer before radiation. This
preparatory procedure did not significantly alter pH, which ranged
from 7.2 to 7.4 depending on cell density. In a separate set of
experiments, the preincubation time varied between 3 and
100 min. Metabolic hypoxia in cell pellets was achieved as
described previously (Verovski et al, 1996). Briefly, SNAP was
added at appropriate concentrations to cells (0.5 ´ 106 in 100 ml of
medium) kept in conical plastic tubes on ice. Pellets of approxi-
mately 0.3—0.4 mm in height were produced by centrifugation at
300 g for 5 min. Metabolic oxygen depletion was induced prior to
radiation by a 10-min incubation at 37°C. Cells in both suspen-
sions and pellets were irradiated at 37°C at a dose rate of 2 Gy
min—1 using an 8-MV photon beam from a linear accelerator and
immediately cooled. The survival of control and irradiated cells
was measured by an 8-day colony formation assay as described
previously (Verovski et al, 1996). To analyse cellular radio-
sensitivity, radiation survival curves were produced after
linear—quadratic fitting of the dose—survival data. The radiation
doses involved were 2, 4, 6 and 8 Gy for oxic cells and 4, 8, 12 and
16 Gy for hypoxic cells. The enhancement ratios for oxygen and
SNAP were calculated at the level of 0.1 survival fraction by
dividing the radiation dose of hypoxic cells by the radiation dose
of oxic cells (or hypoxic cells plus radiosensitizer).
Amperometric measurement of nitric oxide
All measurements were conducted in open vials, at 37°C and with
periodic gentle stirring. Spontaneous NO release from 0.1—10 mM
SNAP was estimated in the absence of cells. The NO signal was
allowed to stabilize for 5 min, after which SNAP was added to the
final concentration. Starting from 6 min, the NO signal was regis-
tered every minute by an Iso-NOP200 microsensor connected to
an ISO-NO Mark II meter (both from World Precision
Instruments, Hertfordshire, UK). The amperometric measure-
ments were expressed in nA. To assess bioreductive generation of
NO, SNAP at 0.1 mM was incubated in medium containing EMT-6
cells (0.1—10 ´ 106 ml—1), and NO measurements were performed
as described above. When used, the NO-specific scavenger
carboxy-PTIO was injected prior to SNAP to produce a final
concentration of 0.3 mM.
Statistics
All assays were repeated at least three times. Data are expressed as
means (symbols) with corresponding standard deviations (bars).
RESULTS
Amperometric measurement of NO generated from
SNAP
The NO release profiles from SNAP in the absence or presence of
EMT-6 cells are summarized in Figure 1. In a cell-free system
(Figure 1A), the NO output decreased 16- and 160-fold with the
dilution of SNAP from 10 to 1 and 0.1 mM respectively. At 0.1 mM
SNAP, addition of EMT-6 cells progressively activated the NO
release up to 50 times at 10 ´ 106 cells ml—1 (Figure 1B). To
ascertain the specificity of the NO sensor under the conditions
used, the NO scavenger carboxy-PTIO was added to the cells
(10 ´ 106 ml—1) before injection of SNAP. This led to a complete
loss of the NO signal.
Radiosensitizing properties of SNAP
The radiosensitizing activity of SNAP was assessed at 0.1 mM, a
concentration that allows us to focus on bioreductive NO genera-
tion because of the low background of spontaneous NO release.
The radiation survival curves of EMT-6 cells in normoxia, and
hypoxia with or without radiosensitizer are shown in Figure 2.
The enhancement ratios for SNAP at cell densities of 0.1, 1 and
10 ´ 106 ml—1 were 1.3, 1.4 and 1.6 respectively, which did not
reflect the considerable changes in NO profiles demonstrated in
Figure 1. The lack of correlation between the NO signal and
radiosensitization at different cell densities was not due to the vari-
ations in hypoxia, which was forced by nitrogen gassing. The
oxygen enhancement ratios were identical (2.8—2.9) and the
radiosensitivity of hypoxic cells was similar for all three cell densi-
ties. The aerobic survival curves did not indicate any shift in
radiosensitivity thus confirming the absence of metabolic oxygen
depletion. Only above 10 ´ 106 ml—1 did aerated cells reveal signifi-
cant radioprotection due to metabolic oxygen depletion (data not
shown), and therefore these conditions were excluded from
analysis of both radiosensitivity and NO release. We tested the
effect of carboxy-PTIO, an NO scavenger, on the radiosensitizing
activity of SNAP at a cell density of 10 ´ 106 ml—1. Half-reversal of
radiosensitization was observed although complete scavenging of
the extracellular NO was confirmed by the NO microsensor (see
Figure 1B). Using the same cell density, we further investigated the
radiosensitizing activity of SNAP in a range of concentrations
between 0.01 and 1 mM. Figure 3 summarizes the enhancement
ratios of different concentrations of SNAP calculated from survival
curves (not shown). We observed an increase of the enhancement
ratios with rising concentrations of SNAP, levelling out at 1.6—1.7.
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SNAP described here is significantly less than the data of Mitchell
et al (1996), who found an enhancement ratio of 2.6 for 1 mM
SNAP in V79 lung fibroblasts metabolically depleted of oxygen.
Therefore, the activity of SNAP was reevaluated in cell pellets, a
model of metabolic hypoxia previously applied to SNP (Verovski
et al, 1996). When compared with nitrogen-gassed cell suspen-
sions, freely aerated pellets provided a decreased level of hypoxia
with an oxygen enhancement ratio of 2.5 (Figure 4). No significant
change in the enhancement ratios (1.5—1.9) for 0.1—1 mM SNAP
was observed.
Bioactivation rate of SNAP in hypoxia
As NO measurements had indicated fast decomposition of SNAP
in the presence of cells (Figure 1), we decided to investigate the
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Figure 1 Amperometric measurement of NO released from SNAP at 37°C
in the absence (A) or in the presence (B) of EMT-6 cells. The NO signal was
allowed to stabilize during 5 min and afterwards SNAP was added as
indicated by the arrows. (A) SNAP was incubated at concentrations of 0.1
(s s), 1 (s s) and 10 mM (s s). (B) SNAP (0.1 mM) was incubated in a cell
suspension containing 0.1 ´ 106 (l l), 1 ´ 106 (l l) and 10 ´ 106 (l l) cells ml–1.
The NO scavenger carboxy-PTIO was added to the cells (10 ´ 106 ml–1)
immediately before SNAP (l)
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Figure 2 Radiosensitizing activity of SNAP (0.1 mM) in EMT-6 cells at cell
densities of 0.1 (A), 1 (B) and 10 (C) ´ 106 ml–1 in a model of nitrogen-
induced hypoxia. Cell survival in normoxia (l l), hypoxia (s s), hypoxia + SNAP
(l) or hypoxia + SNAP + carboxy-PTIO (s) was estimated by a colony
formation assaybioactivation rate of SNAP in hypoxia with regard to radiosensi-
tizing activity. EMT-6 cells were preincubated with the radiosensi-
tizer for different time periods up to 100 min and the cell survival
at 8 Gy was estimated (Figure 5). Between 3 and 30 min, an
increase in radiosensitization was observed followed by a signifi-
cant decline at 100 min. A similar decline in radiosensitization
was found for the NO donor PAPA/NO, which is known to
undergo decomposition in a purely spontaneous way with a half-
life of 15 min (Maragos et al, 1991). Therefore the biological half-
life of SNAP is unlikely to exceed 30 min.
DISCUSSION
In the present study, the role of bioreductive NO release from
SNAP in hypoxic cell radiosensitization was evaluated. Hypoxia
was induced by nitrogen gassing because radiosensitization was to
be performed at low cell densities. Hypoxic EMT-6 cells treated
with SNAP in a broad range of cell (0.1—10 ´ 106 ml—1) and
radiosensitizer (0.01—1 mM) concentrations clearly showed
increased response to radiation with a maximal enhancement ratio
of 1.7. This activity is far less than the observation of Mitchell et al
(1996), who used V79 lung fibroblasts in a model of metabolic
hypoxia and reported enhancement ratios of 2.5—2.6 for 0.1—1 mM
SNAP. With the same approach, many other NO donors
(DEA/NO, SPER/NO, GSNO, SNP) were investigated, and in
some but not all cell lines enhancement ratios close to that of
oxygen (2.6—3.0) were observed (Mitchell et al, 1993, 1996;
Griffin et al, 1996; Verovski et al, 1996).
The reduced activity of SNAP in EMT-6 cells may reflect a
diminished sensitivity of these cells to NO or, alternatively, could
be associated with the use of nitrogen gassing to induce hypoxia.
To check out the latter possibility, EMT-6 cells were metabolically
depleted of oxygen in cell pellets, a method previously applied to
sodium nitroprusside (SNP) (Verovski et al, 1996). In these condi-
tions, SNAP demonstrated a maximal enhancement ratio of 1.9,
which is still less than that (2.5—2.6) found in V79 lung fibroblasts
(Mitchell et al, 1996). Therefore, we believe that the most likely
explanation for this discrepancy is a cell-dependent variation in
the activity of SNAP. Significant variability in the radiosensitizing
effect of the bioreductive NO donor SNP was described earlier in
human pancreatic cell lines (Verovski et al, 1996). Such a phenom-
enon might be especially prominent for bioreductive agents whose
catalytic transformations are expected to be cell specific. We spec-
ulated that the release of NO from SNAP proceeds in a bioreduc-
tive way that is analogous to SNP, and hence SNAP may also
reveal a variable radiosensitizing potential. We focus further
analysis on the hypothesis of a bioreductive mechanism of NO
generation from SNAP; while the evaluation of its radiosensitizing
potency with regard to different cell lines and hypoxia models is a
matter for future experiments.
Using a NO specific microsensor, we measured the release of
NO from SNAP in the absence or presence of EMT-6 cells, and the
corresponding mechanisms were referred to as spontaneous and
bioreductive. This interpretation does not imply intracellular
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Figure 3 Concentration dependency of the radiosensitizing activity of
SNAP. Hypoxic EMT-6 cells (10 ´ 106 ml–1) were exposed to 0.01–1 mM
SNAP for 10 min prior to radiation and the enhancement ratio was calculated
from the surviving curves
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Figure 4 Radiosensitizing activity of SNAP in EMT-6 cells in a model of
metabolism-induced hypoxia in pellets. Cells were irradiated in absence (l)
or presence of SNAP at 0.1 mM (s s) or 1 mM (n n) and cell survival was
estimated by a colony formation assay. The cell survival curve in normoxia
(l l) in cell suspensions from Figure 2A was also plotted for reference
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Figure 5 Radiosensitizing activity of SNAP (s s) and PAPA/NO (l l) in
hypoxic EMT-6 cells as a function of preincubation time. Cells (10 ´ 106 ml–1)
were preincubated during 3–100 min with 0.3 mM radiosensitizer, irradiated at
8 Gy and analysed for survival. The cell survival without radiosensitizer in
normoxia and hypoxia is indicated by arrowstransformations through reductases known to activate classical
bioreductive cytotoxines (Adams, 1992), because highly polar S-
nitrosothiols are unlikely to penetrate biological membranes easily
(Kowaluk et al, 1990). Instead, activation at the cellular membrane
resulting in reductive release of NO or its direct transfer towards
thiols and other nucleophilic targets is being considered (Bates et
al, 1991; Kowaluk et al, 1992; Rochelle et al, 1994). We found that
the generation of NO from SNAP was strongly dependent on cell
density, indicating bioreductive catalysis to be a predominant
mechanism of NO release. Actually, spontaneous liberation of NO
was only significant at a concentration of 1.0 mM SNAP or more,
in line with the data of Mitchell et al (1996). The addition of cells
up to 10 ´ 106 ml—1 resulted in a 50-fold increase in the NO signal,
which became apparent at 0.1 mM SNAP, a concentration found to
cause radiosensitization. The level of NO release, however, did not
correspond to the radiosensitizing activity, as also observed by
Mitchell et al (1996). A 16-fold decline in the NO signal was
observed after dilution of the cell suspension to 0.1 ´ 106 ml—1,
whereas radiosensitization decreased only twofold. In addition,
only half-reversal in SNAP-induced radiosensitization was
obtained in the presence of the NO scavenger carboxy-PTIO,
though the NO signal disappeared completely. Conceivably, the
radiosensitization observed despite a very low NO signal may be
attributed to the intracellular NO pool, which cannot be detected
by the NO sensor nor scavenged by carboxy-PTIO. This agent is
believed not to cross the cell membrane and would therefore not
be capable of neutralizing the intracellular NO, which exists
primarily in the form of S-nitrosothiols. In particular, intracellular
glutathione is thought to be an important intermediary of the
bioactive NO pool (Ignarro et al, 1981; Clancy et al, 1994), consis-
tent with the radiosensitizing properties of GSNO (Mitchell et al,
1996; Verovski et al, 1996).
We also investigated the impact of timing on radiosensitization
because NO measurements has shown accelerated decomposition
of SNAP in the presence of cells. The experimental protocols to
preincubate hypoxic cells with NO donors vary in different
reports, and a time period between 2 to 10 half-lives was arbitrarily
taken, aiming at maximization of the NO level (Mitchell et al,
1993, 1996; Griffin et al, 1996; Verovski et al, 1996). This
approach is difficult to apply to SNAP, a chemical with a half-life
of more than 4 h (Ignarro et al, 1981). A loss of radiosensitizing
activity between 30 and 100 min preincubation time was found in
a manner close to the radiosensitizing profile of PAPA/NO, a NO
donor with a half-life of 15 min. Therefore, the biological half-
life of SNAP is unlikely to exceed 30 min at a cell density of
10 ´ 106 ml—1. An accelerated decomposition of S-nitrosothiols
under physiological conditions has already been suggested in the
literature to explain the discrepancy between their chemical and
biological properties (Kowaluk et al, 1992). Conceivably, not only
the presence of cells but also hypoxic conditions may influence the
stability of SNAP. The latter possibility is supported by the data of
Ioannidis et al (1996), who found a faster decomposition and
higher cytotoxicity of SNAP in hypoxia compared with aerobic
conditions.
In conclusion, the negligible rate of SNAP decomposition in a
cell-free system argues against the role of spontaneous NO
liberation in hypoxic cell radiosensitization. On the contrary, bio-
reductive NO generation from SNAP at radiobiologically active
concentrations is an order of magnitude higher and is therefore
more likely to sustain radiosensitization.
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ABBREVIATIONS
carboxy-PTIO, 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazo-
line-1-oxyl-3-oxide; DEA/NO, 2-(N,N-diethylamino)-diazenolate-
2-oxide-Na+; GSNO, S-nitroso-L-glutathione; NO, nitric oxide;
PAPA/NO, (2)-1-[N-(3-ammoniopropyl)-N-(n-propyl)amino)diazen-
1-ium-1,2-diolate]; SNAP, S-nitroso-N-acetylpenicillamine; SNP,
sodium nitroprusside; SPER/NO, (Z)-1-{N-[3-aminopropyl]-N-[4-
(3-aminopropylammonio)butyl-amino}-diazen-1-ium-1,2-diolate
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